This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 13 print issues and online access
$259.00 per year
only $19.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
McCulloch DEW, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, et al. Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysis. Neurosci Biobehav Rev. 2022;138:104689.
Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition. Psychopharmacology. 2018;235:2915–27.
Pokorny T, Duerler P, Seifritz E, Vollenweider FX, Preller KH. LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making. Psychological Med. 2019;50:2255–64.
Carter OL, Hasler F, Pettigrew JD, Wallis GM, Liu GB, Vollenweider FX. Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans. Psychopharmacology. 2007;195:415–24.
Nagamine M, Yoshino A, Miyazaki M, Takahashi Y, Nomura S. Effects of selective 5-HT 1A agonist tandospirone on the rate and rhythmicity of binocular rivalry. Psychopharmacology. 2008;198:279–86.
Azimi Z, Barzan R, Spoida K, Surdin T, Wollenweber P, Mark MD, et al. Separable gain control of ongoing and evoked activity in the visual cortex by serotonergic input. Elife. 2020;9:e53552.
Funding
This work was supported by the Johns Hopkins Center for Psychedelic and Consciousness Research, which was funded by a generous gift from the Steven and Alexandra Cohen Foundation, Tim Ferriss, Matt Mullenweg, Blake Mycoskie, and Craig Nerenberg.
Author information
Authors and Affiliations
Contributions
NHH and FSB both conceptualized and drafted the work, revised critically, and approved the final version.
Corresponding author
Ethics declarations
Competing interests
FSB has received research funding from the Wana Brand Foundation, is a scientific advisor for WavePaths, Ltd, has received compensation as a consultant for Gilgamesh Pharmaceuticals, Inc, and has received compensation as a consultant for and holds stock in MindState Design Labs, LLC. These entities have had no role in the conception of this article, or the decision to publish. NHH has no competing interests to disclose.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Heller, N.H., Barrett, F.S. Teaching a new dog old tricks: bringing rigor, grounding, and specificity to psychedelic neuropsychopharmacology. Neuropsychopharmacol. (2024). https://doi.org/10.1038/s41386-024-01954-8
Published:
DOI: https://doi.org/10.1038/s41386-024-01954-8